About Company
AlphaLife Sciences is an AI-first platform company transforming how novel therapies navigate the complex path from lab to market. Founded in 2020 and headquartered in New Jersey and Singapore, we bridge deep regulatory expertise with AI innovation to solve critical bottlenecks in drug development. Our mission is to streamline the submission lifecycle through the AuroraPrime platform, which powers nonclinical, clinical, CMC, safety, and labeling documentation across the entire drug lifecycle.
By infusing built-in AI agents into life sciences workflows—from data extraction and authoring to quality control, change management and cross-functional review—AuroraPrime delivers compliant, submission-ready regulatory dossiers with unprecedented speed. The platform provides comprehensive eCTD coverage, significantly accelerating critical IND, NDA, BLA, and MAA filings.
Our team combines world-class engineering talent—over 80% from industry leaders such as Google, Microsoft, and Medidata—with deep domain expertise in pharma and regulatory writing. Validated by strategic partners including Microsoft, NVIDIA, Veeva, and Johnson & Johnson, AlphaLife is building the new standard in regulatory automation. Today, the AuroraPrime platform is trusted and adopted by more than half of the top 20 global pharmaceutical companies to deliver enterprise-scale, regulatory-grade impact.
Vision, Mission, and Key Pillar Products
Our Vision is to accelerate global drug development—making it faster and more affordable through AI. Our Mission is to automate life-science content authoring and insight generation with AI, enabling biopharma teams to achieve greater efficiency, quality, and compliance. Our four pillar product lines, in both production and roadmap, are delivered through the AuroraPrime suite—a scalable, hyperscaler-powered GenAI platform built on Content Authoring, Content Insights, an AI Platform for Developers, and 360° Clinical Efficiency—together enabling true end-to-end drug lifecycle transformation.
Leadership Team
Sharon Chen
CEOFormer Director of Google R&D; Former General Manager of Verily APAC
Gavin Zhang
Chief Business OfficerFormer Head of Channel Sales Asia Pacific of Medidata; Former Key Account Solution Sales at Microsoft
Bogong Zhu
Chief Product OfficerFormer Senior Technical Supervisor at Google & Verily
Pengcheng Xu
Chief Technology OfficerEngineering Lead at Google; Former Engineering Architect at Verily
Advisory Board
Jean-Marie Geoffroy
Former Vice President, Sterile Injectables Design, Pfizer; Former Director & Senior Fellow, Takeda; Former Director & Research Investigator, Abbott.
Karen Devcich
Former Vice President, Medical Writing, Quality & Editing and Clinical Trial Transparency, ICON; Former Vice President, Global Medical Writing, Takeda.
Névine Zariffa
Former SVP, Head of Biometrics & Information Sciences, AZ; Former Vice President at Large & Emerging Pipeline, GSK; Board member of CDISC.
Brand Story
In 2020, a group of senior technology and product experts from Google and Verily decided to start a business and delve into the intelligent digitalization of life science clinical research. With the goal of building a SaaS platform for life science and consumer health fields through world-leading computer technology, AlphaLife Sciences was officially established in August 2020. With the vision of "Use technology to advance innovation in life science and consumer health. Faster, more accessible and evidence-based," the AlphaLife team quickly grew and attracted many technology talents from leading global IT companies and senior industry experts from the life sciences field. With the gradual launch of AlphaLife's innovative products, more and more leading life science innovation and development companies, as well as ecosystem partners, choose AlphaLife, collaborate in multiple ways, and jointly explore the future of intelligent digitalization in clinical research.
Our global network and support
With experienced staff and trusted partners worldwide, we provide comprehensive support to ensure you have the resources you need, wherever you are.
-
New Jersey
-
San Francisco
-
Philadelphia
-
Singapore
-
Switzerland
-
Shanghai